Total Funding
1
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Aerovance is a biotech company focused on developing and commercializing medicines for respiratory and allergic diseases.
About the Company
Aerovance is a privately held biopharmaceutical company exclusively focused on developing and commercializing breakthrough medicines for respiratory and allergic diseases. The company maintains a solid intellectual property position with its strong portfolio of novel therapeutic candidates now in clinical development and several pre-clinical
programs. The two lead products are human recombinant proteins: Aerovant™, an IL-4 and -13 receptor antagonist which is in Phase IIa studies for asthma and Aeroderm™, a PEGylated IL-4 and IL-13 receptor antagonist in pre-clinical studies for eczema.
